Our Bureau, Mumbai Monday, August 25, 2025, 17:20 Hrs [IST] ...

Our Bureau, Mumbai Monday, August 25, 2025, 09:00 Hrs [IST] ...

South & Southeast Asian nations unite to strengthen health research systems through collaboration: Our Bureau, Mumbai Monday, ...

Lighthouse Pharma receives $49.2 million grant from NIA to advance phase 2 study of LHP588 for P. gingivalis-positive Alzheimer's disease: San Francisco, California Monday, August ...

BlossomHill Therapeutics begins patient dosing in expansion cohorts of the phase 1/2 SOLARA trial of BH-30643 in advanced EGFR-mutant NSCLC: San Diego Monday, August 25, 2025, 14: ...

Health Canada approves Moderna’s updated Covid-19 mRNA vaccine, Spikevax, targeting SARS-CoV-2 variant LP.8.1 ...

US FDA approves Esaote’s ultrasound systems, MyLab A50 and MyLab A70: Genoa, Italy Monday, August 25, 2025, 15:00 Hrs [IST] Esaote, a leader in medical device manufacturing in t ...

Pharmexcil engages in strategic deliberations on pharma & medical devices sectors with DoP and CWS: Shardul Nautiyal, Mumbai Monday, August 25, 2025, 08:00 Hrs [IST] In a crucial ...

Bio-Thera & STADA agree to extend biosimilars alliance to cover tocilizumab to treat multiple inflammatory and autoimmune disorders: Bad Vilbel, Germany Monday, August 25, 2025, 1 ...

Using vaginal estrogen tablets was not associated with an increased risk of recurrent ischemic stroke among postmenopausal women in a registry in Denmark, according to research published in Stroke, ...

The US Food and Drug Administration (FDA) began daily publication of adverse event data from the FDA Adverse Event Reporting System (FAERS). This represents a significant step forward in modernizing ...

Parliamentary Panel urges DoP to address issues related to fund utilisation in PLI schemes: Gireesh Babu, New Delhi Monday, August 25, 2025, 08:00 Hrs [IST] Expressing concerns ov ...